APO Research
Talk to an analyst

APO RESEARCH · REPORT

Asthma Medication

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Asthma Medication Industry Growth and Trends Forecast to 2032

26 December 2025107 pages

Choose your research edition.

Industry ResearchAsthma Medication Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Asthma Medication Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Asthma Medication Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Asthma Medication Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Asthma Medication Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Asthma Medication market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Asthma Medication is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Asthma Medication is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Asthma Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Asthma Medication include Merck & Co. Inc, Roche Holdings Ltd, Glaxosmithkline plc, AstraZeneca plc, Theravance Inc, Sepracor, Inc, Schering-Plough Corp, Sanofi-Aventis and QVAR, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Asthma Medication market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Asthma Medication market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Asthma Medication market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Asthma Medication.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Asthma Medication market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Asthma Medication Market by Company

Merck & Co. Inc

Roche Holdings Ltd

Glaxosmithkline plc

AstraZeneca plc

Theravance Inc

Sepracor, Inc

Schering-Plough Corp

Sanofi-Aventis

QVAR

MAP Pharmaceuticals，Inc

Genentech Inc

Dulera

Asthma Medication Segment by Type

Asthma Medications During Pregnancy

Quick-Relief Medications

Long-Term Control Medications

Asthma Medication Segment by Application

Children

Adolescent

Adult

Asthma Medication Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Asthma Medication market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Asthma Medication and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Asthma Medication.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Asthma Medication manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Asthma Medication in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Asthma Medications During Pregnancy Table 2. Major Company of Quick-Relief Medications Table 3. Major Company of Long-Term Control Medications Table 4. Global Asthma Medication Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Asthma Medication Sales by Type (2021-2026) & (K Units) Table 6. Global Asthma Medication Sales Market Share in Volume by Type (2021-2026) Table 7. Global Asthma Medication Sales by Type (2021-2026) & (US$ Million) Table 8. Global Asthma Medication Sales Market Share in Value by Type (2021-2026) Table 9. Global Asthma Medication Price by Type (2021-2026) & (US$/Unit) Table 10. Global Asthma Medication Sales by Type (2027-2032) & (K Units) Table 11. Global Asthma Medication Sales Market Share in Volume by Type (2027-2032) Table 12. Global Asthma Medication Sales by Type (2027-2032) & (US$ Million) Table 13. Global Asthma Medication Sales Market Share in Value by Type (2027-2032) Table 14. Global Asthma Medication Price by Type (2027-2032) & (US$/Unit) Table 15. North America Asthma Medication Sales by Type (2021-2026) & (K Units) Table 16. North America Asthma Medication Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Asthma Medication Sales by Type (2021-2026) & (K Units) Table 18. Europe Asthma Medication Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Asthma Medication Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Asthma Medication Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Asthma Medication Sales by Type (2021-2026) & (K Units) Table 22. Latin America Asthma Medication Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Asthma Medication Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Asthma Medication Sales by Type (2021-2026) & (US$ Million) Table 25. Asthma Medication Industry Trends Table 26. Asthma Medication Industry Drivers Table 27. Asthma Medication Industry Opportunities and Challenges Table 28. Asthma Medication Industry Restraints Table 29. Global Asthma Medication Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Asthma Medication Revenue Market Share by Company (2021-2026) Table 31. Global Asthma Medication Sales by Company (2021-2026) & (K Units) Table 32. Global Asthma Medication Sales Share by Company (2021-2026) Table 33. Global Asthma Medication Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Asthma Medication Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Asthma Medication Major Company Production Sites and Headquarters Table 36. Global Asthma Medication Company, Product Type & Application Table 37. Global Asthma Medication Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Asthma Medication by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Asthma Medication Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Asthma Medication Sales by Region (2021-2026) & (K Units) Table 42. Global Asthma Medication Sales Market Share in Volume by Region (2021-2026) Table 43. Global Asthma Medication Sales by Region (2021-2026) & (US$ Million) Table 44. Global Asthma Medication Sales Market Share in Value by Region (2021-2026) Table 45. Global Asthma Medication Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Asthma Medication Sales by Region (2027-2032) & (K Units) Table 47. Global Asthma Medication Sales Market Share in Volume by Region (2027-2032) Table 48. Global Asthma Medication Sales by Region (2027-2032) & (US$ Million) Table 49. Global Asthma Medication Sales Market Share in Value by Region (2027-2032) Table 50. Global Asthma Medication Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Asthma Medication Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Asthma Medication Sales by Application (2021-2026) & (K Units) Table 53. Global Asthma Medication Sales Market Share in Volume by Application (2021-2026) Table 54. Global Asthma Medication Sales by Application (2021-2026) & (US$ Million) Table 55. Global Asthma Medication Sales Market Share in Value by Application (2021-2026) Table 56. Global Asthma Medication Price by Application (2021-2026) & (US$/Unit) Table 57. Global Asthma Medication Sales by Application (2027-2032) & (K Units) Table 58. Global Asthma Medication Sales Market Share in Volume by Application (2027-2032) Table 59. Global Asthma Medication Sales by Application (2027-2032) & (US$ Million) Table 60. Global Asthma Medication Sales Market Share in Value by Application (2027-2032) Table 61. Global Asthma Medication Price by Application (2027-2032) & (US$/Unit) Table 62. North America Asthma Medication Sales by Application (2021-2026) & (K Units) Table 63. North America Asthma Medication Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Asthma Medication Sales by Application (2021-2026) & (K Units) Table 65. Europe Asthma Medication Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Asthma Medication Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Asthma Medication Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Asthma Medication Sales by Application (2021-2026) & (K Units) Table 69. Latin America Asthma Medication Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Asthma Medication Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Asthma Medication Sales by Application (2021-2026) & (US$ Million) Table 72. Merck & Co. Inc Company Information Table 73. Merck & Co. Inc Business Overview Table 74. Merck & Co. Inc Asthma Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Merck & Co. Inc Asthma Medication Product Portfolio Table 76. Merck & Co. Inc Recent Development Table 77. Roche Holdings Ltd Company Information Table 78. Roche Holdings Ltd Business Overview Table 79. Roche Holdings Ltd Asthma Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Roche Holdings Ltd Asthma Medication Product Portfolio Table 81. Roche Holdings Ltd Recent Development Table 82. Glaxosmithkline plc Company Information Table 83. Glaxosmithkline plc Business Overview Table 84. Glaxosmithkline plc Asthma Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Glaxosmithkline plc Asthma Medication Product Portfolio Table 86. Glaxosmithkline plc Recent Development Table 87. AstraZeneca plc Company Information Table 88. AstraZeneca plc Business Overview Table 89. AstraZeneca plc Asthma Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. AstraZeneca plc Asthma Medication Product Portfolio Table 91. AstraZeneca plc Recent Development Table 92. Theravance Inc Company Information Table 93. Theravance Inc Business Overview Table 94. Theravance Inc Asthma Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Theravance Inc Asthma Medication Product Portfolio Table 96. Theravance Inc Recent Development Table 97. Sepracor, Inc Company Information Table 98. Sepracor, Inc Business Overview Table 99. Sepracor, Inc Asthma Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Sepracor, Inc Asthma Medication Product Portfolio Table 101. Sepracor, Inc Recent Development Table 102. Schering-Plough Corp Company Information Table 103. Schering-Plough Corp Business Overview Table 104. Schering-Plough Corp Asthma Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Schering-Plough Corp Asthma Medication Product Portfolio Table 106. Schering-Plough Corp Recent Development Table 107. Sanofi-Aventis Company Information Table 108. Sanofi-Aventis Business Overview Table 109. Sanofi-Aventis Asthma Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Sanofi-Aventis Asthma Medication Product Portfolio Table 111. Sanofi-Aventis Recent Development Table 112. QVAR Company Information Table 113. QVAR Business Overview Table 114. QVAR Asthma Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. QVAR Asthma Medication Product Portfolio Table 116. QVAR Recent Development Table 117. MAP Pharmaceuticals，Inc Company Information Table 118. MAP Pharmaceuticals，Inc Business Overview Table 119. MAP Pharmaceuticals，Inc Asthma Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. MAP Pharmaceuticals，Inc Asthma Medication Product Portfolio Table 121. MAP Pharmaceuticals，Inc Recent Development Table 122. Genentech Inc Company Information Table 123. Genentech Inc Business Overview Table 124. Genentech Inc Asthma Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Genentech Inc Asthma Medication Product Portfolio Table 126. Genentech Inc Recent Development Table 127. Dulera Company Information Table 128. Dulera Business Overview Table 129. Dulera Asthma Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Dulera Asthma Medication Product Portfolio Table 131. Dulera Recent Development Table 132. North America Asthma Medication Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 133. North America Asthma Medication Sales by Country (2021-2026) & (K Units) Table 134. North America Asthma Medication Sales Market Share by Country (2021-2026) Table 135. North America Asthma Medication Sales Forecast by Country (2027-2032) & (K Units) Table 136. North America Asthma Medication Sales Market Share Forecast by Country (2027-2032) Table 137. North America Asthma Medication Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. North America Asthma Medication Market Size by Country (2021-2026) & (US$ Million) Table 139. North America Asthma Medication Market Share by Country (2021-2026) Table 140. North America Asthma Medication Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. North America Asthma Medication Market Share Forecast by Country (2027-2032) Table 142. Europe Asthma Medication Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 143. Europe Asthma Medication Sales by Country (2021-2026) & (K Units) Table 144. Europe Asthma Medication Sales Market Share by Country (2021-2026) Table 145. Europe Asthma Medication Sales Forecast by Country (2027-2032) & (K Units) Table 146. Europe Asthma Medication Sales Market Share Forecast by Country (2027-2032) Table 147. Europe Asthma Medication Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Europe Asthma Medication Market Size by Country (2021-2026) & (US$ Million) Table 149. Europe Asthma Medication Market Share by Country (2021-2026) Table 150. Europe Asthma Medication Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Europe Asthma Medication Market Share Forecast by Country (2027-2032) Table 152. Asia-Pacific Asthma Medication Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 153. Asia-Pacific Asthma Medication Sales by Country (2021-2026) & (K Units) Table 154. Asia-Pacific Asthma Medication Sales Market Share by Country (2021-2026) Table 155. Asia-Pacific Asthma Medication Sales Forecast by Country (2027-2032) & (K Units) Table 156. Asia-Pacific Asthma Medication Sales Market Share Forecast by Country (2027-2032) Table 157. Asia-Pacific Asthma Medication Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Asia-Pacific Asthma Medication Market Size by Country (2021-2026) & (US$ Million) Table 159. Asia-Pacific Asthma Medication Market Share by Country (2021-2026) Table 160. Asia-Pacific Asthma Medication Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Asia-Pacific Asthma Medication Market Share Forecast by Country (2027-2032) Table 162. Latin America Asthma Medication Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 163. Latin America Asthma Medication Sales by Country (2021-2026) & (K Units) Table 164. Latin America Asthma Medication Sales Market Share by Country (2021-2026) Table 165. Latin America Asthma Medication Sales Forecast by Country (2027-2032) & (K Units) Table 166. Latin America Asthma Medication Sales Market Share Forecast by Country (2027-2032) Table 167. Latin America Asthma Medication Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Latin America Asthma Medication Market Size by Country (2021-2026) & (US$ Million) Table 169. Latin America Asthma Medication Market Share by Country (2021-2026) Table 170. Latin America Asthma Medication Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Latin America Asthma Medication Market Share Forecast by Country (2027-2032) Table 172. Middle East and Africa Asthma Medication Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 173. Middle East and Africa Asthma Medication Sales by Country (2021-2026) & (K Units) Table 174. Middle East and Africa Asthma Medication Sales Market Share by Country (2021-2026) Table 175. Middle East and Africa Asthma Medication Sales Forecast by Country (2027-2032) & (K Units) Table 176. Middle East and Africa Asthma Medication Sales Market Share Forecast by Country (2027-2032) Table 177. Middle East and Africa Asthma Medication Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 178. Middle East and Africa Asthma Medication Market Size by Country (2021-2026) & (US$ Million) Table 179. Middle East and Africa Asthma Medication Market Share by Country (2021-2026) Table 180. Middle East and Africa Asthma Medication Market Size Forecast by Country (2027-2032) & (US$ Million) Table 181. Middle East and Africa Asthma Medication Market Share Forecast by Country (2027-2032) Table 182. Key Raw Materials Table 183. Raw Materials Key Suppliers Table 184. Asthma Medication Distributors List Table 185. Asthma Medication Customers List Table 186. Research Programs/Design for This Report Table 187. Authors List of This Report Table 188. Secondary Sources Table 189. Primary Sources List of Figures Figure 1. Asthma Medication Image Figure 2. Global Asthma Medication Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Asthma Medication Market Size (2021-2032) & (US$ Million) Figure 4. Global Asthma Medication Sales (2021-2032) & (K Units) Figure 5. Asthma Medications During Pregnancy Image Figure 6. Global Asthma Medications During Pregnancy Sales YoY Growth (2021-2032) & (K Units) Figure 7. Quick-Relief Medications Image Figure 8. Global Quick-Relief Medications Sales YoY Growth (2021-2032) & (K Units) Figure 9. Long-Term Control Medications Image Figure 10. Global Long-Term Control Medications Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Asthma Medication Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Asthma Medication Market Share by Type 2025 VS 2032 Figure 13. North America Asthma Medication Sales Market Share in Volume by Type in 2025 Figure 14. North America Asthma Medication Sales Market Share in Value by Type in 2025 Figure 15. Europe Asthma Medication Sales Market Share in Volume by Type in 2025 Figure 16. Europe Asthma Medication Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Asthma Medication Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Asthma Medication Sales Market Share in Value by Type in 2025 Figure 19. Latin America Asthma Medication Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Asthma Medication Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Asthma Medication Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Asthma Medication Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Asthma Medication Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Children Image Figure 26. Global Children Sales YoY Growth (2021-2032) & (K Units) Figure 27. Adolescent Image Figure 28. Global Adolescent Sales YoY Growth (2021-2032) & (K Units) Figure 29. Adult Image Figure 30. Global Adult Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Asthma Medication Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Asthma Medication Market Share by Application 2025 VS 2032 Figure 33. North America Asthma Medication Sales Market Share in Volume by Application in 2025 Figure 34. North America Asthma Medication Sales Market Share in Value by Application in 2025 Figure 35. Europe Asthma Medication Sales Market Share in Volume by Application in 2025 Figure 36. Europe Asthma Medication Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Asthma Medication Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Asthma Medication Sales Market Share in Value by Application in 2025 Figure 39. Latin America Asthma Medication Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Asthma Medication Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Asthma Medication Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Asthma Medication Sales Market Share in Value by Application in 2025 Figure 43. North America Asthma Medication Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Asthma Medication Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Asthma Medication Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Asthma Medication Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Asthma Medication Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Asthma Medication Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Asthma Medication Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Asthma Medication Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Asthma Medication Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Asthma Medication Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Asthma Medication Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Asthma Medication Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Asthma Medication Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Asthma Medication Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Asthma Medication Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Asthma Medication Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Asthma Medication Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Asthma Medication Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Asthma Medication Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Asthma Medication Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asthma Medication Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Asthma Medication Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Asthma Medications During Pregnancy
  • Quick-Relief Medications
  • Long-Term Control Medications
Applications
  • Children
  • Adolescent
  • Adult
Companies covered
  • Merck & Co. Inc
  • Roche Holdings Ltd
  • Glaxosmithkline plc
  • AstraZeneca plc
  • Theravance Inc
  • Sepracor, Inc
  • Schering-Plough Corp
  • Sanofi-Aventis
  • QVAR
  • MAP Pharmaceuticals，Inc
  • Genentech Inc
  • Dulera

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Asthma Medication Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Asthma Medication Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Asthma Medication Market by Type
  6. 1.3.1 Asthma Medications During Pregnancy
  7. 1.3.2 Quick-Relief Medications
  8. 1.3.3 Long-Term Control Medications
  9. 1.4 Global Asthma Medication Market Size by Type
  10. 1.4.1 Global Asthma Medication Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Asthma Medication Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Asthma Medication Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Asthma Medication Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Asthma Medication Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Asthma Medication Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Asthma Medication Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Asthma Medication Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Asthma Medication Industry Trends
  2. 2.2 Asthma Medication Industry Drivers
  3. 2.3 Asthma Medication Industry Opportunities and Challenges
  4. 2.4 Asthma Medication Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Asthma Medication Revenue (2021-2026)
  2. 3.2 Global Top Players by Asthma Medication Sales (2021-2026)
  3. 3.3 Global Top Players by Asthma Medication Price (2021-2026)
  4. 3.4 Global Asthma Medication Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Asthma Medication Major Company Production Sites & Headquarters
  6. 3.6 Global Asthma Medication Company, Product Type & Application
  7. 3.7 Global Asthma Medication Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Asthma Medication Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Asthma Medication Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Asthma Medication Tier 1, Tier 2, and Tier 3
4 Asthma Medication Regional Status and Outlook
  1. 4.1 Global Asthma Medication Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Asthma Medication Historic Market Size by Region
  3. 4.2.1 Global Asthma Medication Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Asthma Medication Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Asthma Medication Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Asthma Medication Forecasted Market Size by Region
  7. 4.3.1 Global Asthma Medication Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Asthma Medication Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Asthma Medication Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Asthma Medication by Application
  1. 5.1 Asthma Medication Market by Application
  2. 5.1.1 Children
  3. 5.1.2 Adolescent
  4. 5.1.3 Adult
  5. 5.2 Global Asthma Medication Market Size by Application
  6. 5.2.1 Global Asthma Medication Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Asthma Medication Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Asthma Medication Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Asthma Medication Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Asthma Medication Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Asthma Medication Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Asthma Medication Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Asthma Medication Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Merck & Co. Inc
  2. 6.1.1 Merck & Co. Inc Company Information
  3. 6.1.2 Merck & Co. Inc Business Overview
  4. 6.1.3 Merck & Co. Inc Asthma Medication Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Merck & Co. Inc Asthma Medication Product Portfolio
  6. 6.1.5 Merck & Co. Inc Recent Developments
  7. 6.2 Roche Holdings Ltd
  8. 6.2.1 Roche Holdings Ltd Company Information
  9. 6.2.2 Roche Holdings Ltd Business Overview
  10. 6.2.3 Roche Holdings Ltd Asthma Medication Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Roche Holdings Ltd Asthma Medication Product Portfolio
  12. 6.2.5 Roche Holdings Ltd Recent Developments
  13. 6.3 Glaxosmithkline plc
  14. 6.3.1 Glaxosmithkline plc Company Information
  15. 6.3.2 Glaxosmithkline plc Business Overview
  16. 6.3.3 Glaxosmithkline plc Asthma Medication Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Glaxosmithkline plc Asthma Medication Product Portfolio
  18. 6.3.5 Glaxosmithkline plc Recent Developments
  19. 6.4 AstraZeneca plc
  20. 6.4.1 AstraZeneca plc Company Information
  21. 6.4.2 AstraZeneca plc Business Overview
  22. 6.4.3 AstraZeneca plc Asthma Medication Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 AstraZeneca plc Asthma Medication Product Portfolio
  24. 6.4.5 AstraZeneca plc Recent Developments
  25. 6.5 Theravance Inc
  26. 6.5.1 Theravance Inc Company Information
  27. 6.5.2 Theravance Inc Business Overview
  28. 6.5.3 Theravance Inc Asthma Medication Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Theravance Inc Asthma Medication Product Portfolio
  30. 6.5.5 Theravance Inc Recent Developments
  31. 6.6 Sepracor, Inc
  32. 6.6.1 Sepracor, Inc Company Information
  33. 6.6.2 Sepracor, Inc Business Overview
  34. 6.6.3 Sepracor, Inc Asthma Medication Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Sepracor, Inc Asthma Medication Product Portfolio
  36. 6.6.5 Sepracor, Inc Recent Developments
  37. 6.7 Schering-Plough Corp
  38. 6.7.1 Schering-Plough Corp Company Information
  39. 6.7.2 Schering-Plough Corp Business Overview
  40. 6.7.3 Schering-Plough Corp Asthma Medication Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Schering-Plough Corp Asthma Medication Product Portfolio
  42. 6.7.5 Schering-Plough Corp Recent Developments
  43. 6.8 Sanofi-Aventis
  44. 6.8.1 Sanofi-Aventis Company Information
  45. 6.8.2 Sanofi-Aventis Business Overview
  46. 6.8.3 Sanofi-Aventis Asthma Medication Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Sanofi-Aventis Asthma Medication Product Portfolio
  48. 6.8.5 Sanofi-Aventis Recent Developments
  49. 6.9 QVAR
  50. 6.9.1 QVAR Company Information
  51. 6.9.2 QVAR Business Overview
  52. 6.9.3 QVAR Asthma Medication Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 QVAR Asthma Medication Product Portfolio
  54. 6.9.5 QVAR Recent Developments
  55. 6.10 MAP Pharmaceuticals，Inc
  56. 6.10.1 MAP Pharmaceuticals，Inc Company Information
  57. 6.10.2 MAP Pharmaceuticals，Inc Business Overview
  58. 6.10.3 MAP Pharmaceuticals，Inc Asthma Medication Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 MAP Pharmaceuticals，Inc Asthma Medication Product Portfolio
  60. 6.10.5 MAP Pharmaceuticals，Inc Recent Developments
  61. 6.11 Genentech Inc
  62. 6.11.1 Genentech Inc Company Information
  63. 6.11.2 Genentech Inc Business Overview
  64. 6.11.3 Genentech Inc Asthma Medication Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Genentech Inc Asthma Medication Product Portfolio
  66. 6.11.5 Genentech Inc Recent Developments
  67. 6.12 Dulera
  68. 6.12.1 Dulera Company Information
  69. 6.12.2 Dulera Business Overview
  70. 6.12.3 Dulera Asthma Medication Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Dulera Asthma Medication Product Portfolio
  72. 6.12.5 Dulera Recent Developments
7 North America by Country
  1. 7.1 North America Asthma Medication Sales by Country
  2. 7.1.1 North America Asthma Medication Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Asthma Medication Sales by Country (2021-2026)
  4. 7.1.3 North America Asthma Medication Sales Forecast by Country (2027-2032)
  5. 7.2 North America Asthma Medication Market Size by Country
  6. 7.2.1 North America Asthma Medication Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Asthma Medication Market Size by Country (2021-2026)
  8. 7.2.3 North America Asthma Medication Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Asthma Medication Sales by Country
  2. 8.1.1 Europe Asthma Medication Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Asthma Medication Sales by Country (2021-2026)
  4. 8.1.3 Europe Asthma Medication Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Asthma Medication Market Size by Country
  6. 8.2.1 Europe Asthma Medication Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Asthma Medication Market Size by Country (2021-2026)
  8. 8.2.3 Europe Asthma Medication Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Asthma Medication Sales by Country
  2. 9.1.1 Asia-Pacific Asthma Medication Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Asthma Medication Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Asthma Medication Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Asthma Medication Market Size by Country
  6. 9.2.1 Asia-Pacific Asthma Medication Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Asthma Medication Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Asthma Medication Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Asthma Medication Sales by Country
  2. 10.1.1 South America Asthma Medication Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Asthma Medication Sales by Country (2021-2026)
  4. 10.1.3 South America Asthma Medication Sales Forecast by Country (2027-2032)
  5. 10.2 South America Asthma Medication Market Size by Country
  6. 10.2.1 South America Asthma Medication Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Asthma Medication Market Size by Country (2021-2026)
  8. 10.2.3 South America Asthma Medication Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Asthma Medication Sales by Country
  2. 11.1.1 Middle East and Africa Asthma Medication Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Asthma Medication Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Asthma Medication Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Asthma Medication Market Size by Country
  6. 11.2.1 Middle East and Africa Asthma Medication Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Asthma Medication Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Asthma Medication Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Asthma Medication Value Chain Analysis
  2. 12.1.1 Asthma Medication Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Asthma Medication Production Mode & Process
  7. 12.2 Asthma Medication Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Asthma Medication Distributors
  10. 12.2.3 Asthma Medication Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst